BLCM
Bellicum Pharmaceuticals, Inc.
BLCM
BLCM
Delisted
BLCM was delisted on the 1st of June, 2023.
92 hedge funds and large institutions have $68.7M invested in Bellicum Pharmaceuticals, Inc. in 2018 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 23 increasing their positions, 29 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
54% less capital invested
Capital invested by funds: $150M → $68.7M (-$81.4M)
Holders
92
Holding in Top 10
–
Calls
$38K
Puts
$34K
Top Buyers
| 1 | +$1.32M | |
| 2 | +$1.29M | |
| 3 | +$532K | |
| 4 |
Two Sigma Investments
New York
|
+$502K |
| 5 |
RhumbLine Advisers
Boston,
Massachusetts
|
+$372K |
Top Sellers
| 1 | -$3.32M | |
| 2 | -$1.45M | |
| 3 | -$1.23M | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$1.02M |
| 5 |
RI
RTW Investments
New York
|
-$970K |